Christopher Goetz to Organic Chemicals
This is a "connection" page, showing publications Christopher Goetz has written about Organic Chemicals.
Connection Strength
0.162
-
Placebo influences on dyskinesia in Parkinson's disease. Mov Disord. 2008 Apr 15; 23(5):700-7.
Score: 0.077
-
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial. Mov Disord. 2007 Jan 15; 22(2):179-86.
Score: 0.070
-
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). Clin Neuropharmacol. 2004 Mar-Apr; 27(2):58-62.
Score: 0.014